Doug Baker transitions to executive vice president of finance and accounting ROCHESTER, Mich. , Sept. 30, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced the
Digital solutions provide new opportunities to support brand and HCP patient engagement challenges in survey of top U.S. endocrinologists ROCHESTER, Mich. , Sept. 29, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions
Launch of digital solution supports major industry paradigm shift towards improving patient care and adherence through technology ROCHESTER, Mich. , Sept. 14, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping
D’Silva Brings Over 10 Years of Equity Research Experience ROCHESTER, Mich. , Sept. 08, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has appointed Andrew D’Silva to the
OptimizeRx Recognized in the COVID-19 Pandemic-Related Campaign Category ROCHESTER, Mich. , Sept. 07, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that it
ROCHESTER, Mich. , Sept. 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s CEO, will present at the upcoming Lake Street
The Companies’ combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction ROCHESTER, Mich. , Aug. 17, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies,
- Revenue Up 55% to $13.6 million , closing on 19 enterprise contracts - Enterprise deals pipeline grows from 46 to 63 - Brands adopting OptimizeRx solutions increases to 140 from 80 in the past 6 months - Successful implementation of evidence-based provider engagement programs, driven by
ROCHESTER, Mich. , July 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Wednesday, August 4, 2021, at 4:30 p.m.
OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans ROCHESTER, Mich. , July 14, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life
